|
Headlines
Market news and breaking stories live from Dow Jones Newswires
Market Commentary
A technical analysis commentary of the major markets, only from INO
Smart Scan
A premium service, alerting you to changes in the market by web and email.
Extreme Futures / Stocks
Extreme Markets from all exchanges, updated throughout the trading day.
|
| |
|
Trade Triangle Technology, Advanced Charts, SmartScan, Trading Workshops.
The premier online video learning platform for traders.
Daily Portfolio Scan and Analysis
|
| |
|
Sanofi-Aventis' Multaq receives European approval71 days ago
(AP:NEW YORK) Drug developer Sanofi-Aventis said Monday its irregular heart rhythm drug Multaq received regulatory approval in the European Union.
The European Commission granted approval for the drug, which clears the way for sales in all 27 European member states. The drug is already approved in the U.S.
Shares of Paris-based Sanofi-Aventis closed at $38.43 Friday.
Copyright 2009 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.
< Back to News Index
|
